These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5371175)

  • 1. [Effect of acid protective coating on absorption of erythromycin at oral administration].
    Koroleva VG; Belozerova OP; Vasil'ev VK; Stepnaia VE
    Antibiotiki; 1969 Dec; 14(12):1084-8. PubMed ID: 5371175
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of film formers and plasticizers on the stability of resistance and disintegration behavior. 4. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K; Heckenmüller H
    Pharmazie; 1987 Dec; 42(12):837-41. PubMed ID: 3444846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of microencapsulation with ethyl cellulose upon the disintegration in vivo and the dissolution of iron tablets.
    Dahlström H; Eriksson S
    Acta Pharm Suec; 1971 Nov; 8(5):505-8. PubMed ID: 5159520
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective comparison of patient tolerance to enteric-coated vs nonenteric-coated erythromycin.
    Ellsworth AJ; Christensen DB; Volpone-McMahon MT
    J Fam Pract; 1990 Sep; 31(3):265-70. PubMed ID: 2202773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the absorption of the combined administration of erythromycin and bromohexine hydrochloride].
    Höffler D; Nebe K; Wiethoff EO
    Arzneimittelforschung; 1972 Jan; 22(1):97-100. PubMed ID: 5067008
    [No Abstract]   [Full Text] [Related]  

  • 6. Intra- and intersubject variation of erythromycin absorption from single-unit and multiple-unit enteric-coated products.
    Graffner C; Josefsson K; Stockman O
    Biopharm Drug Dispos; 1986; 7(2):163-71. PubMed ID: 3708122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythromycin absorption in healthy volunteers from single and multiple doses of enteric-coated pellets and tablets.
    Hovi T; Josefsson K; Renkonen OV
    Eur J Clin Pharmacol; 1983; 25(2):271-3. PubMed ID: 6628511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological availability of erythromycin granules for children's use].
    Korenev SV; Garsheva GB; Nesterova LIa; Grakovskaia LK; Tentsova AI
    Antibiot Khimioter; 1990 Aug; 35(8):14-6. PubMed ID: 2264745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of poly(styrene-alt-maleic anhydride)-ethanol as enteric coating material.
    Lai X; Sun C; Tian H; Zhao W; Gao L
    Int J Pharm; 2008 Mar; 352(1-2):66-73. PubMed ID: 18054184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption of erythromycin. A cross-over study in healthy volunteers.
    Männistö P; Tuomisto J; Räsänen R
    Arzneimittelforschung; 1975 Nov; 25(11):1828-31. PubMed ID: 1106445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of erythromycin stearate and enteric-coated erythromycin base after a single oral dose immediately before breakfast.
    Schreiner A; Digranes A
    Infection; 1984; 12(5):345-8. PubMed ID: 6511088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of study design in assessing food effects on absorption of erythromycin base and erythromycin stearate.
    DiSanto AR; Chodos DJ
    Antimicrob Agents Chemother; 1981 Aug; 20(2):190-6. PubMed ID: 7283417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some galenic procedures used in the substitution therapy with Lactobacillus acidophilus].
    Gumma A; Mirimanoff A
    Pharm Acta Helv; 1971 May; 46(5):278-89. PubMed ID: 4997965
    [No Abstract]   [Full Text] [Related]  

  • 14. [Enteric coating].
    Delporte JP
    Pharm Acta Helv; 1970 Sep; 45(9):525-52. PubMed ID: 4918879
    [No Abstract]   [Full Text] [Related]  

  • 15. GLC determination of erythromycin in enteric-coated tablets.
    Robertson JH; Tsuji K
    J Pharm Sci; 1972 Oct; 61(10):1633-5. PubMed ID: 5072414
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of intestinal amebiasis using erythromycin stearate of normal release with enteric coating (A-16535). Study of 13 cases. Preliminary report].
    Molina Pasquel C; Hernández y Silva J; Rosas M
    Rev Invest Salud Publica; 1967; 27(4):321-6. PubMed ID: 5618959
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythromycin in the aqueous humour.
    Shorr N; Mack LW; Smith JL
    Br J Ophthalmol; 1969 May; 53(5):331-4. PubMed ID: 5772618
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic studies following oral administration of erythropoietin mucoadhesive tablets to beagle dogs.
    Venkatesan N; Yoshimitsu J; Ohashi Y; Ito Y; Sugioka N; Shibata N; Takada K
    Int J Pharm; 2006 Mar; 310(1-2):46-52. PubMed ID: 16439074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses.
    Yakatan GJ; Rasmussen CE; Feis PJ; Wallen S
    J Clin Pharmacol; 1985; 25(1):36-42. PubMed ID: 3871797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of dissolving pH of enteric coating agent on bioavailability of enteric coated tablets of erythromycin in man (author's transl)].
    Watanabe Y; Sano M; Motohashi K; Yoneda R
    Yakugaku Zasshi; 1978 Aug; 98(8):1092-100. PubMed ID: 30834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.